RoweWPHartleyJWWatermanSTurnerHCHuebnerRJ. Cytopathogenic agent resembling human salivary gland virus recovered from tissue cultures of human adenoids. Proc Soc Exp Biol Med1956; 92418–424.
2.
SmithMG. Propagation in tissue cultures of a cytopathogenic virus from human salivary gland virus (SGV) disease. Proc Soc Exp Biol Med1956; 92: 424–430.
3.
WellerTHMacauleyJCCraigJMWirthP. Isolation of intranuclear inclusion producing agents from infants with illnesses resembling cytomegalic inclusion disease. Proc Soc Exp Biol Med1957; 94: 4–12.
4.
BrowningJDMoreIARBoydJF. Adult pulmonary cytomegalic inclusion disease: report of a case. J Clin Pathol1980; 33: 11–18.
5.
Leading Article. Should renal-transplant patients be screened for CMV?Lancet1978; 2: 770–771.
6.
CraigheadJE. Immunologic response to cytomegalovirus infection in renal allograft recipients. Am J Epidemiol1969; 90: 506–513.
7.
NagingtonJ. Cytomegalovirus antibody production in renal transplant patients. J Hyg (Camb)1971; 69: 645–660.
8.
MeyersJDSpencerHCWattsJCGreggMBStewartJATroupinRHThomasED. Cytomegalovirus pneumonia after human marrow transplantation. Ann Intern Med1975; 82: 181–188.
9.
HuangE-SRocheJK. Cytomegalovirus DNA and adenocarcinoma of the colon: evidence for latent viral infection. Lancet1978; 1: 957–960.
